These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9861478)

  • 1. Cerebrospinal fluid levels of oxytocin in Prader-Willi syndrome: a preliminary report.
    Martin A; State M; Anderson GM; Kaye WM; Hanchett JM; McConaha CW; North WG; Leckman JF
    Biol Psychiatry; 1998 Dec; 44(12):1349-52. PubMed ID: 9861478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated cerebrospinal fluid levels of oxytocin in obsessive-compulsive disorder. Comparison with Tourette's syndrome and healthy controls.
    Leckman JF; Goodman WK; North WG; Chappell PB; Price LH; Pauls DL; Anderson GM; Riddle MA; McSwiggan-Hardin M; McDougle CJ
    Arch Gen Psychiatry; 1994 Oct; 51(10):782-92. PubMed ID: 7524462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linking oxytocin and arginine vasopressin signaling abnormalities to social behavior impairments in Prader-Willi syndrome.
    Oztan O; Zyga O; Stafford DEJ; Parker KJ
    Neurosci Biobehav Rev; 2022 Nov; 142():104870. PubMed ID: 36113782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated plasma oxytocin levels in children with Prader-Willi syndrome compared with healthy unrelated siblings.
    Johnson L; Manzardo AM; Miller JL; Driscoll DJ; Butler MG
    Am J Med Genet A; 2016 Mar; 170(3):594-601. PubMed ID: 26615966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between endogenous oxytocin and vasopressin levels and the Prader-Willi syndrome behaviour phenotype.
    Rice LJ; Agu J; Carter CS; Harris JC; Nazarloo HP; Naanai H; Einfeld SL
    Front Endocrinol (Lausanne); 2023; 14():1183525. PubMed ID: 37313445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in the hypothalamic paraventricular nucleus and its oxytocin neurons (putative satiety cells) in Prader-Willi syndrome: a study of five cases.
    Swaab DF; Purba JS; Hofman MA
    J Clin Endocrinol Metab; 1995 Feb; 80(2):573-9. PubMed ID: 7852523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promising effects of oxytocin on social and food-related behaviour in young children with Prader-Willi syndrome: a randomized, double-blind, controlled crossover trial.
    Kuppens RJ; Donze SH; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2016 Dec; 85(6):979-987. PubMed ID: 27486141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid monoamines in Prader-Willi syndrome.
    Akefeldt A; Ekman R; Gillberg C; Månsson JE
    Biol Psychiatry; 1998 Dec; 44(12):1321-8. PubMed ID: 9861475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxytocin treatment in children with Prader-Willi syndrome: A double-blind, placebo-controlled, crossover study.
    Miller JL; Tamura R; Butler MG; Kimonis V; Sulsona C; Gold JA; Driscoll DJ
    Am J Med Genet A; 2017 May; 173(5):1243-1250. PubMed ID: 28371242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind randomized controlled trial of oxytocin nasal spray in Prader Willi syndrome.
    Einfeld SL; Smith E; McGregor IS; Steinbeck K; Taffe J; Rice LJ; Horstead SK; Rogers N; Hodge MA; Guastella AJ
    Am J Med Genet A; 2014 Sep; 164A(9):2232-9. PubMed ID: 24980612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obsessive-compulsive symptoms in Prader-Willi and "Prader-Willi-Like" patients.
    State MW; Dykens EM; Rosner B; Martin A; King BH
    J Am Acad Child Adolesc Psychiatry; 1999 Mar; 38(3):329-34. PubMed ID: 10087695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxytocin and Prader-Willi Syndrome.
    Kabasakalian A; Ferretti CJ; Hollander E
    Curr Top Behav Neurosci; 2018; 35():529-557. PubMed ID: 28956320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prader-Willi syndrome: From genetics to behaviour, with special focus on appetite treatments.
    Griggs JL; Sinnayah P; Mathai ML
    Neurosci Biobehav Rev; 2015 Dec; 59():155-72. PubMed ID: 26475993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum ghrelin levels are inversely correlated with body mass index, age, and insulin concentrations in normal children and are markedly increased in Prader-Willi syndrome.
    Haqq AM; Farooqi IS; O'Rahilly S; Stadler DD; Rosenfeld RG; Pratt KL; LaFranchi SH; Purnell JQ
    J Clin Endocrinol Metab; 2003 Jan; 88(1):174-8. PubMed ID: 12519848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal Carbetocin Reduces Hyperphagia, Anxiousness, and Distress in Prader-Willi Syndrome: CARE-PWS Phase 3 Trial.
    Roof E; Deal CL; McCandless SE; Cowan RL; Miller JL; Hamilton JK; Roeder ER; McCormack SE; Roshan Lal TR; Abdul-Latif HD; Haqq AM; Obrynba KS; Torchen LC; Vidmar AP; Viskochil DH; Chanoine JP; Lam CKL; Pierce MJ; Williams LL; Bird LM; Butler MG; Jensen DE; Myers SE; Oatman OJ; Baskaran C; Chalmers LJ; Fu C; Alos N; McLean SD; Shah A; Whitman BY; Blumenstein BA; Leonard SF; Ernest JP; Cormier JW; Cotter SP; Ryman DC
    J Clin Endocrinol Metab; 2023 Jun; 108(7):1696-1708. PubMed ID: 36633570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxytocin in young children with Prader-Willi syndrome: Results of a randomized, double-blind, placebo-controlled, crossover trial investigating 3 months of oxytocin.
    Damen L; Grootjen LN; Juriaans AF; Donze SH; Huisman TM; Visser JA; Delhanty PJD; Hokken-Koelega ACS
    Clin Endocrinol (Oxf); 2021 May; 94(5):774-785. PubMed ID: 33296519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid function from birth to adolescence in Prader-Willi syndrome.
    Sharkia M; Michaud S; Berthier MT; Giguère Y; Stewart L; Deladoëy J; Deal C; Van Vliet G; Chanoine JP
    J Pediatr; 2013 Sep; 163(3):800-5. PubMed ID: 23623517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study.
    Whitman BY; Myers S; Carrel A; Allen D
    Pediatrics; 2002 Feb; 109(2):E35. PubMed ID: 11826245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxytocin and vasopressin systems in genetic syndromes and neurodevelopmental disorders.
    Francis SM; Sagar A; Levin-Decanini T; Liu W; Carter CS; Jacob S
    Brain Res; 2014 Sep; 1580():199-218. PubMed ID: 24462936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High circulating ghrelin: a potential cause for hyperphagia and obesity in prader-willi syndrome.
    DelParigi A; Tschöp M; Heiman ML; Salbe AD; Vozarova B; Sell SM; Bunt JC; Tataranni PA
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5461-4. PubMed ID: 12466337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.